Skip to content
A4584Assembly2019-2020 Session

Update Unused Drug Return Rules

Official title

“Provides that residential health care facilities may return and redistribute unused medication”

Sponsor Steven EnglebrightAD-4+1 co-sponsorAffects Health
Status
In Assembly Committee
Health
Impact
5/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill updates unused medication return rules for residential health care facilities and compensates participating pharmacies.

Why it matters

  1. Statewide safeguards. Returned drugs would need original, unopened, tamper-evident packaging and specified FDA-approved containers. Controlled substances would remain excluded, and pharmacies could still decline returns.

  2. Pharmacy compensation. The health commissioner would set a fee reimbursing pharmacies for receiving, restocking and redistributing drugs, with advice from a new committee of long-term care pharmacists.

  3. Privacy and liability. The commissioner would establish HIPAA-compliant return procedures. Drug manufacturers would gain protection from civil and criminal liability for donated drugs under the program, absent bad faith.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Residential health care facilities

    Pharmacists’ designees could handle returns, subject to the revised packaging requirements.

  • Long-term care pharmacies

    Participating pharmacies would receive a cost-reimbursement fee and help advise on its development.

  • State Department of Health

    The department would convene the advisory committee, while the commissioner would set fees and privacy procedures.

  • Prescription drug manufacturers

    The bill would shield them from specified liability involving donated drugs unless they act in bad faith.

Headline styles

Update Unused Drug Return Rules

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Steven Englebright

Assembly Member · Assembly District 4

1 Co-sponsor

History

  1. Referred to health
  2. Referred to health

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

4584

2019-2020 Regular Sessions

IN ASSEMBLY

February 4, 2019

Introduced by M. of A. ENGLEBRIGHT, LUPARDO -- read once and referred to the Committee on Health

AN ACT to amend the public health law, in relation to return and redistribution of unused medication

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Section 2803-e of the public health law, as added by chapter 902 of the laws of 1977 and renumbered by chapter 340 of the laws of 1980, is amended to read as follows:

§ 2803-e. Residential health care facilities; return and redistribution of unused medication. 1. Notwithstanding any inconsistent provision of law, rule or regulation to the contrary, the commissioner is hereby authorized and directed to permit either a resident or consultant pharmacist or his or her designee in a residential health care facility to return to the pharmacy from which it was purchased any unused medication provided that such medication is sealed in the manufacturer's original unopened[,] tamper evident packaging and either individually packaged [units] or packaged in unit-dose packaging and within the recommended period of shelf life, and, if oral or parenteral medications, sealed in single-dose containers approved by the federal Food and Drug Administration, and, if a topical or inhalant drug, is sealed in units-of-use containers approved by the federal Food and Drug Administration and provided that such medication is not a controlled substance as defined in section thirty-three hundred six of [the public health law] this chapter.

2. The pharmacy to which such medication as described in subdivision one of this section is returned shall be permitted to receive, restock and redistribute that medication. The commissioner, in consultation with the advisory committee established by subdivision six of this section, shall establish a reasonable fee of reimbursement of costs

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD09062-01-9

A. 4584 2

related to the receipt, restocking and redistribution of such medication payable to the pharmacy to which such medication is returned.

3. The pharmacy to which such medication as described in subdivision one of this section is returned shall be required to reimburse or credit the purchaser of that medication for the unused medication that is restocked and redistributed. No pharmacy shall be required to accept any medication returned under subdivision one of this section.

4. Neither an individual patient or the state, if a patient is a recipient of a state funded program, shall be charged for unused medication which according to the provisions of this law is returned for reimbursement or credit.

5. The commissioner shall establish procedures to assure that any return of medications authorized by this section, and any receipt, restocking or redistribution of medication so returned shall comply with the federal Health Insurance Portability and Accountability Act (HIPAA) of 1996, as amended.

6. The department shall convene an advisory committee to assist the commissioner in developing a reasonable fee of reimbursement pursuant to the provisions of subdivision two of this section. The advisory committee shall be comprised of licensed pharmacists currently engaged in the provision of long term care pharmacy services. Members of the committee shall be appointed by the governor: two members of the committee shall be appointed on the recommendation of the temporary president of the senate and the speaker of the assembly; and two members shall be appointed on the recommendation of the minority leader of the assembly and the minority leader of the senate.

7. A prescription drug manufacturer shall not, in the absence of bad faith, be subject to criminal or civil liability for injury, death, or loss to person or property for matters related to the return, donation, acceptance, redistribution or dispensing of a prescription drug manufactured by the prescription drug manufacturer that is donated by any person under the program, including but not limited to liability for failure to transfer or communicate product or consumer information or the expiration date of the donated prescription drug.

§ 2. This act shall take effect on the one hundred twentieth day after it shall have become a law. Effective immediately the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such date.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.